HEPA Shares Outstanding History
Below is a table of the HEPA shares outstanding history going back to 6/3/2019:

Date HEPA Shares Outstanding

Also see: HEPA Market Cap History
HEPA Historical Shares Outstanding:
+311.08% CAGR
HEPA Historical Shares Outstanding: +311.08% CAGR

Mouse over chart for data details
6/3/2019 ...11/9/2022
Hepion Pharmaceuticals is a biopharmaceutical company focused on the development of drug therapy for treatment of chronic liver diseases. This therapeutic approach targets fibrosis and hepatocellular carcinoma associated with non-alcoholic steatohepatitis, viral hepatitis, and other liver diseases. Co.'s cyclophilin inhibitor, CRV431, is being developed to address these pathologies. CRV431 is a pan cyclophilin inhibitor that targets multiple pathologic pathways involved in the progression of liver disease. CRV431 additionally shows in vitro antiviral activity towards hepatitis B, C, and D viruses which also trigger liver disease. We show 16 historical shares outstanding datapoints in our coverage of HEPA's shares outstanding history.

Understanding the changing numbers of HEPA shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like HEPA versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching HEPA by allowing them to research HEPA shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree HEPA Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Hepion Pharmaceuticals (HEPA) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

HGEN Shares Outstanding History
HILS Shares Outstanding History
HJLI Shares Outstanding History
HLTH Shares Outstanding History
HLVX Shares Outstanding History
HMSY Shares Outstanding History
HNGR Shares Outstanding History
HOLX Shares Outstanding History
HOOK Shares Outstanding History
HOTH Shares Outstanding History
More Healthcare companies »


HEPA Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2023, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.